FDA 483 - American Regent Inc. - July 20, 2023

American Regent Inc. in Hilliard, OH, a manufacturer of sterile drugs, was inspected by the FDA from July 10-20, 2023. The inspection revealed significant deficiencies in production and process control procedures, as well as failures within the quality control unit. These issues indicate a lack of adherence to good manufacturing practices and proper documentation.